Urinary excretion of fatty acid-binding proteins in idiopathic membranous nephropathy

被引:34
作者
Hofstra, Julia M. [1 ]
Deegens, Jeroen K. J. [1 ]
Steenbergen, Eric J. [2 ]
Wetzels, Jack F. M. [1 ]
机构
[1] Radboud Univ Nijmegen, Med Ctr, Dept Nephrol, NL-6500 HB Nijmegen, Netherlands
[2] Radboud Univ Nijmegen, Med Ctr, Dept Pathol, NL-6500 HB Nijmegen, Netherlands
关键词
fatty acid-binding protein; H-FABP; L-FABP; membranous nephropathy; renal outcome;
D O I
10.1093/ndt/gfn190
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. It is suggested that proteinuria contributes to progressive renal failure by inducing tubular cell injury. The site of injury is unknown. Most studies have used markers of proximal tubular cell damage. Fatty acid-binding proteins (FABPs) are intracellular carrier proteins with different expression in the kidney. Liver-type FABP (L-FABP) is found in the cytoplasm of proximal tubules, whereas heart-type FABP (H-FABP) is localized in the distal tubules. We evaluated the urinary excretion of L-FABP and H-FABP in patients with idiopathic membranous nephropathy (iMN). Methods. We have studied 40 patients (27 males, 13 females) with iMN. The mean age was 48 +/- 15 years, serum creatinine concentration 89 +/- 17 mu mol/l and proteinuria 8.9 +/- 5.0 g/24 h. Urinary L-FABP and H-FABP were measured by ELISA. Renal failure was defined as an increase in serum creatinine > 25% from baseline with a serum creatinine > 135 mu mol/l or an increase > 50% from baseline. Urinary L-FABP excretion was detectable in all but one patient. The median (range) level was 3.29 (0.7-165.6) mu g/mmol creatinine (normal < 0.38 mu g/mmol Cr). Urinary H-FABP was undetectable in nine patients. Median level was 1.53 (0.1-90.5) mu g/mmol Cr (normal < 0.1 mu g/mmol Cr). Both L- and H-FABP correlated with urinary beta 2-microglobulin, urinary alpha 1-microglobulin and IgG. Urinary H-FABP paralleled L-FABP. Results. After a mean follow-up of 75 +/- 32 months, 16 (40%) patients have reached the predefined end point of renal failure. Both urinary L-FABP and H-FABP predicted renal outcome, with the calculated sensitivity and specificity of 81 and 83% for both. Conclusions. Urinary L-FABP and urinary H-FABP are increased in patients with iMN. There was a high correlation between L-FABP and H-FABP, suggesting the concurrent development or existence of proximal and distal tubular cell injury. Both L-FABP and H-FABP predicted prognosis in patients with iMN. These markers may be of interest as research tools; however, they are not superior to more conventional marker proteins.
引用
收藏
页码:3160 / 3165
页数:6
相关论文
共 21 条
  • [1] Urinary N-acetyl-β-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis
    Bazzi, C
    Petrini, C
    Rizza, V
    Arrigo, G
    Napodano, P
    Paparella, M
    D'Amico, G
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 (11) : 1890 - 1896
  • [2] Urinary excretion of IgG and α1-microglobulin predicts clinical course better than extent of proteinuria in membranous nephropathy
    Bazzi, C
    Petrini, C
    Rizza, V
    Arrigo, G
    Beltrame, A
    Pisano, L
    D'Amico, G
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 38 (02) : 240 - 248
  • [3] Urinary excretion of β2-microglobulin and IgG predict prognosis in idiopathic membranous nephropathy:: A validation study
    Branten, AJW
    du Buf-Vereijken, PW
    Klasen, IS
    Bosch, FH
    Feith, GW
    Hollander, DA
    Wetzels, JF
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (01): : 169 - 174
  • [4] Validation of a predictive model of idiopathic membranous nephropathy: Its clinical and research implications
    Cattran, DC
    Pei, Y
    Greenwood, CMT
    Ponticelli, C
    Passerini, P
    Honkanen, E
    [J]. KIDNEY INTERNATIONAL, 1997, 51 (03) : 901 - 907
  • [5] TUBULOINTERSTITIAL DAMAGE IN GLOMERULAR-DISEASES - ITS ROLE IN THE PROGRESSION OF RENAL DAMAGE
    DAMICO, G
    FERRARIO, F
    RASTALDI, MP
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1995, 26 (01) : 124 - 132
  • [6] DAVISON AM, 1984, CLIN NEPHROL, V22, P61
  • [7] Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate
    du Buf-Vereijken, PWG
    Branten, AJW
    Wetzels, JFM
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (05) : 1142 - 1148
  • [8] EDDY AA, 1994, J AM SOC NEPHROL, V5, P1273
  • [9] Unravelling the significance of cellular fatty acid-binding proteins
    Glatz, JFC
    Storch, J
    [J]. CURRENT OPINION IN LIPIDOLOGY, 2001, 12 (03) : 267 - 274
  • [10] Hayashida N, 2001, J CARDIOVASC SURG, V42, P735